Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma

http://www.wikidata.org/entity/Q33594370

about

Emerging role of Hippo pathway in gastric and other gastrointestinal cancers Prognostic significance of TAZ expression in various cancers: a meta-analysis Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β.Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells.HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease.The TAZ-miR-224-SMAD4 axis promotes tumorigenesis in osteosarcoma.The Hippo pathway in chemotherapeutic drug resistance.Overexpression of Yes-associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta-analysis.Upregulation of DACT2 suppresses proliferation and enhances apoptosis of glioma cell via inactivation of YAP signaling pathway Emerging role of Hippo signalling pathway in bladder cancer.Targeting YAP in malignant pleural mesothelioma.Herbal Medicine Offered as an Initiative Therapeutic Option for the Management of Hepatocellular Carcinoma.Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma.YAP and TAZ in epithelial stem cells: A sensor for cell polarity, mechanical forces and tissue damage.miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells YAP/TAZ at the Roots of Cancer.YAP and the Hippo pathway in pediatric cancer.IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway.Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.Clinical Implications of the Hippo-YAP Pathway in Multiple Cancer Contexts.Linking Extracellular Matrix Agrin to the Hippo Pathway in Liver Cancer and Beyond.Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions.Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature.

P2860

Q26774473-9280CFCD-D6BF-44E6-82A9-F7784232642A Q28078348-363CE647-C57B-40CF-9465-7F1C6EFF0BD3 Q35742770-D672EF61-380D-482D-8AB8-BBB08373CDB6 Q35832427-80F25920-3C4C-4095-9E82-0E69D9589A16 Q36544794-F1FCFA92-86DA-489F-A3B5-1BD9CADF9953 Q36557209-DABA17C0-F325-45F7-B7DC-997DBE12B1F9 Q36939981-35E09568-7A55-44ED-9AF6-164333E43D45 Q37580201-E5928F7B-5CB6-4400-8B73-BC2A9F96619C Q37744927-18982C0B-2B93-4CCB-AAE1-1A62849A4FA7 Q38263091-7EBC1EB0-0E78-42A1-A014-2D538565A957 Q38371893-7643FD4C-394C-49B8-BE2C-56857F1D6984 Q38630701-12DB5069-EF14-4BB9-8B9B-34D98CBCBE3D Q38637679-577FBBB7-07B3-476B-9397-7C7DB35237E7 Q38704895-E197106E-7837-4C06-B181-342E0E48CC28 Q38734645-1E795049-DF5A-42ED-8C3B-8BE4300D1687 Q38741468-DFEAE59B-A1AE-4AE5-A684-A5A4A31DF452 Q38833041-69DFBEC0-37B9-4B0C-988B-B546DE4CF347 Q38858548-7C5A3CF6-B2F5-47E5-AD70-A09BC837992E Q38864941-BDFBF590-5B4C-4772-BCF0-07BCB195859B Q39374990-C9B3B377-E771-4D0A-970B-66FBD266309B Q41472551-4982A6B5-EB0A-4FC4-8E6E-F2EA1676ECD4 Q41634975-6C81C196-671D-4C44-8453-ACC375FE9D84 Q49797871-A2DF2B58-09C0-47E1-89DA-2E1205B21A71 Q50131782-861C3C1F-0B95-49A9-83FD-214F444E0E95 Q51713474-DCE782FE-960F-4D72-8859-0FA3DE148815 Q55669129-6798350B-35FC-4F3F-B06A-0FB578A88096

P2860

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma

http://www.wikidata.org/entity/Q33594370

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma

@ast

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma

@en

type

label

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma

@ast

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma

@en

prefLabel

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma

@ast

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma

@en

P1433

Q33594370-884D2ACF-7B88-4F72-A3BE-E073ABB82994

P1476

Q33594370-2192CFED-0E5E-441B-A88D-B3BDEA0158B7

P2093

Q33594370-04A65128-482A-4CF7-BF2B-6025C3B2B28C

Q33594370-142B7A69-D6EF-40A3-882E-AE1FC9D361BC

Q33594370-582E25DA-9F72-466A-9E28-BB1F4C996668

Q33594370-8D7936BC-1B28-4E98-8B7A-685D6BE0C4E0

Q33594370-97EC2825-73F0-4EF2-B586-F0297C71EE3F

Q33594370-BE9D6FC1-C23D-4B7C-9E59-5E6EB8AAFCC1

Q33594370-CF205BF4-0012-4A48-B241-C437E884A273

Q33594370-FACD581B-3E8F-40B9-AC07-80B8C03CD549

P2860

Q33594370-00976BC0-1CBA-470F-B63D-55FDE8CB246B

Q33594370-03B70C94-66CB-4398-BA96-CDCE8DB27E1C

Q33594370-25F254A2-99BC-4A42-9C88-8B0FBA53BCAC

Q33594370-331ABCBC-B816-48EE-8F96-1B96E55934B2

Q33594370-34373A2A-F2C5-493A-BEC5-8A6CBC419BE3

Q33594370-3ACAA62C-5471-4B59-ACD0-7959D18CAA8C

Q33594370-47415D39-E31F-4E8A-B64F-363E08DFB2BC

Q33594370-56473917-995E-4DF3-8316-29D89276C8BC

Q33594370-5963BCFB-6646-4366-82BA-FCAA2E3F1803

Q33594370-68D3D2AA-E4E6-4C2B-86E9-AB8598B3F15C

P304

Q33594370-3CA09481-7FDA-420D-8D40-20F4CF302E1C

P31

Q33594370-5B2CEC33-7F15-4DE4-BC8F-E28FB3550BE8

P356

Q33594370-C063A32C-EDB3-44B4-8C11-6E3D04156DEC

P478

Q33594370-D0F63211-07AD-4FC9-A72A-107DB9DA6E49

P50

Q33594370-B1D8CC60-F2F8-4221-BBB8-92E96D5A73AD

P577

Q33594370-26D387D7-1D04-44D6-9959-67F145625503

P5875

Q33594370-DF5074F2-50A0-48BB-8B6B-CE8157F40996

P698

Q33594370-4A254248-A3BC-4B8B-A15E-6422FB334113

P921

Q33594370-9FAFC23A-2FC8-4C30-8C63-02B078692C6F

P932

Q33594370-FDF9DCCA-E6B3-4654-9B1D-4A73F41572FB

P356

P1433

Journal of Immunology Research

P1476

Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma

@en

P2093

Chen-chen He

http://www.w3.org/2001/XMLSchema#string

E Bai

http://www.w3.org/2001/XMLSchema#string

Gui-hua Jin

http://www.w3.org/2001/XMLSchema#string

Li-juan Wang

http://www.w3.org/2001/XMLSchema#string

Meng Li

http://www.w3.org/2001/XMLSchema#string

Qing Zhu

http://www.w3.org/2001/XMLSchema#string

Xi-jing Guo

http://www.w3.org/2001/XMLSchema#string

Xia Ying

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

Expression of Yes-associated protein in common solid tumors

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

Role of YAP/TAZ in mechanotransduction

Elucidation of a universal size-control mechanism in Drosophila and mammals

YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.

The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.

MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties.

Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.

The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.

P304

261365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/261365

http://www.w3.org/2001/XMLSchema#string

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262644277

http://www.w3.org/2001/XMLSchema#string

P698

24860833

http://www.w3.org/2001/XMLSchema#string

P921

maternal health

P932

4016924

http://www.w3.org/2001/XMLSchema#string